Brief: Pacira BioSciences Notified of Abbreviated New Drug Application Filing from The WhiteOak Group for EXPAREL
21/10/2025 13:35
Oct 21 (Reuters) - Pacira Biosciences Inc PCRX.O: PACIRA BIOSCIENCES NOTIFIED OF ABBREVIATED NEW DRUG APPLICATION FILING FROM THE WHITEOAK GROUP FOR EXPAREL® PACIRA BIOSCIENCES INC - WHITEOAK FILES ANDA FOR GENERIC EXPAREL PACIRA BIOSCIENCES: INTENDS TO ASSERT AND ENFORCE ITS INTELLECTUAL PROPERTY RIGHTS AND HAS 45 DAYS FROM RECEIPT OF PIV NOTICE TO FILE A LAWSUIT Source text: ID:nGNX6XCNkV Further company coverage: PCRX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pacira BioSciences
See all newsUS STOCKS ON THE MOVE-Palantir, Haemonetics
U.S. STOCKS ON THE MOVE-Palantir, Haemonetics, Starbucks
Pacira BioSciences jumps on $1.65 billion Viatris buyout deal
Brief: Viatris - Pacira To Pay Viatris $62 Million Termination Fee Under Specified Circumstances
Pacira BioSciences jumps on $1.65 billion Viatris buyout deal